Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
D000893:Anti-Inflammatory Agents / Q000737:chemistry* / Q000494:pharmacology*; D000935:Antifungal Agents / Q000737:chemistry* / Q000494:pharmacology*; D002478:Cells, Cultured; D015725:Fluconazole / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000737:chemistry* / Q000494:pharmacology*; D017964:Itraconazole / Q000737:chemistry / Q000494:pharmacology; D007654:Ketoconazole / Q000737:chemistry / Q000494:pharmacology; D007975:Leukotriene B4 / Q000037:antagonists & inhibitors / Q000378:metabolism; D015394:Molecular Structure; D009504:Neutrophils / Q000187:drug effects; D010972:Platelet Activating Factor; D011743:Pyrimidines / Q000737:chemistry / Q000494:pharmacology; D014230:Triazoles / Q000737:chemistry / Q000494:pharmacology; D065819:Voriconazole
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D007093:Imidazoles; D010972:Platelet Activating Factor; D011743:Pyrimidines; D014230:Triazoles; D007975:Leukotriene B4; D017964:Itraconazole; D015725:Fluconazole; D065819:Voriconazole; D007654:Ketoconazole